官方服务：
资源简介：
MmPlasma IPAS20_2 late stage breast cancer vs normal
应用场景：
创建时间：
2008-12-31
相关数据集
DataSheet_2_Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.zip
IntroductionProstate adenocarcinoma (PRAD) is a highly aggressive malignancy with high mortality and poor prognosis, and its potential mechanism remains unclear. Our study aimed to identify novel mark
NIAID Data Ecosystem20
A Novel Three Serum Phospholipid Panel Differentiates Normal Individuals from Those with Prostate Cancer
BackgroundThe results of prostate specific antigen (PSA) and digital rectal examination (DRE) screenings lead to both under and over treatment of prostate cancer (PCa). As such, there is an urgent nee
Figshare2016-01-18 更新10
Supplementary Material for: Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data
Background/Aims: MicroRNAs (miRNAs) are promising biomarkers for pancreatic cancer (PaCa). However, systemic and unified evaluations of the diagnostic value of miRNAs are lacking. Therefore, we perfor
Figshare2018-08-30 更新10
Table_7_Pathway Instability Is an Effective New Mutation-Based Type of Cancer Biomarkers.XLSX
DNA mutations play a crucial role in cancer development and progression. Mutation profiles vary dramatically in different cancer types and between individual tumors. Mutations of several individual ge
NIAID Data Ecosystem20
DataSheet_2_Identification of adenylate cyclase 2 methylation in bladder cancer with implications for prognosis and immunosuppressive microenvironment.zip
BackgroundThe incidence and mortality of bladder cancer (BCa) are increasing, while the existing diagnostic methods have limitations. Therefore, for early detection and response prediction, it is cruc
NIAID Data Ecosystem10
